Northern Peptide Collective Research Library
SS-31 Research
SS-31, also known as elamipretide in clinical-development literature, is a mitochondria-targeted tetrapeptide. It has been studied for interactions with mitochondrial membranes and cardiolipin-associated biology.

Compound overview
What is SS-31?
SS-31, also known as elamipretide in clinical-development literature, is a mitochondria-targeted tetrapeptide. It has been studied for interactions with mitochondrial membranes and cardiolipin-associated biology.
Research spans mitochondrial bioenergetics, oxidative stress, membrane structure and disease-model investigations. Evidence includes extensive preclinical work and human clinical-development studies, so study phase and endpoint should be identified carefully.
Research themes
SS-31 research focus
These are literature-navigation themes, not therapeutic claims. Review primary sources for model, methods, formulation, route, endpoints, sample size and limitations.
Independent literature
Researching SS-31
Use primary scientific databases as the starting point. Search results can contain studies using different analogs, salts, formulations or experimental models, so confirm molecular identity before comparing outcomes.
Separate cell and animal models from human trials. Note whether a study is exploratory, randomized, controlled, blinded, replicated or peer reviewed. For investigational compounds, regulatory status should remain explicit.
NPC catalogue
SS-31 research material
Analytical documentation
SS-31 quality, testing & COAs
For research materials, batch-specific documentation is more useful than a generic purity statement. Confirm that analytical documentation identifies the material, lot or batch and test methods used.
Frequently asked questions
SS-31 FAQ
What is SS-31?
SS-31, also known as elamipretide in clinical-development literature, is a mitochondria-targeted tetrapeptide. It has been studied for interactions with mitochondrial membranes and cardiolipin-associated biology.
What research areas are associated with SS-31?
Research spans mitochondrial bioenergetics, oxidative stress, membrane structure and disease-model investigations. Evidence includes extensive preclinical work and human clinical-development studies, so study phase and endpoint should be identified carefully.
How strong is the evidence for SS-31?
The evidence context for this hub is: Preclinical research with clinical-development literature. Review primary sources and distinguish preclinical models from human clinical research.
Where can I find independent SS-31 research?
Use PubMed, ClinicalTrials.gov where relevant, journal databases and the references within peer-reviewed review articles. Search by both the compound name and known aliases.
How do I verify an NPC SS-31 batch?
Use NPC's COA Verification resources and match documentation to the exact product lot where batch-specific records are available.
Does this page provide dosing or medical guidance?
No. Northern Peptide Collective products and this research library are for research purposes only and are not intended for human consumption or medical use.
